Aram Bidikian Profile
Aram Bidikian

@ABidikianMD

Followers
669
Following
1K
Statuses
215

PGY-2 @YaleIMed | Former researcher @MDAndersonnews Leukemia | MD @AUB_Lebanon | My tweets are my own | RTs are not endorsements

Joined October 2020
Don't wanna be here? Send us removal request.
@ABidikianMD
Aram Bidikian
2 years
Thrilled to start my new journey at @YaleIMed with fantastic people. Grateful for the support of my family, friends and amazing mentors at @AUB_Lebanon, @AUBMC_Official and @MDAndersonNews
Tweet media one
55
10
382
@ABidikianMD
Aram Bidikian
1 month
RT @SChung_Lab: Honored to contribute to this study by @SJMorrison_ and team. In patients undergoing allogeneic transplantation and receivi…
0
9
0
@ABidikianMD
Aram Bidikian
1 month
RT @SJMorrison_: Congrats to Jinsuke Nishino, @StephenChung16 , @AshKishtagari, @huwenhuo on paper in Cancer Discovery today: use of non-se…
0
13
0
@ABidikianMD
Aram Bidikian
1 month
RT @YaleCancer: New research @YaleHematology shows early mortality in acute promyelocytic leukemia #APL is high but could improve w/timely…
0
1
0
@ABidikianMD
Aram Bidikian
2 months
RT @smbenlazar: Acute Promyelocytic Leukemia in the Real World: Understanding Outcome Differences and How We Can Improve Them https://t.co/…
0
11
0
@ABidikianMD
Aram Bidikian
2 months
RT @Dr_AmerZeidan: @Yale @YaleCancer research advances presented at American Society of Hematology annual meeting
0
3
0
@ABidikianMD
Aram Bidikian
2 months
0
0
1
@ABidikianMD
Aram Bidikian
2 months
RT @NaydaBidikian: Thrilled to present our award achieving abstract on longitudinal single-cell immune profiling of patients with HRSMM and…
0
3
0
@ABidikianMD
Aram Bidikian
2 months
RT @DanaFarber: We’re kicking off day 2 of #ASH24 with @NaydaBidikian, MD discussing how the immune system responds differently to Teclista…
0
2
0
@ABidikianMD
Aram Bidikian
2 months
RT @YaleCancer: .@Dr_AmerZeidan shares exciting interim results of the phase 1a KOMET-007 trial for patients with acute myeloid leukemia #A
0
5
0
@ABidikianMD
Aram Bidikian
2 months
RT @Dr_AmerZeidan: An outstanding review on #APL by our super star @Yale @YaleMed @YaleIMed @YaleCancer @TradIMYale super star resident @AB
0
4
0
@ABidikianMD
Aram Bidikian
2 months
@Dr_AmerZeidan @Yale @YaleMed @YaleIMed @YaleCancer @TradIMYale @Cancers_MDPI Thank you so much Dr. @Dr_AmerZeidan! Always grateful for your support
0
0
1
@ABidikianMD
Aram Bidikian
2 months
RT @MarkDSiegel1: Congratulations to @TradIMYale PGY2 @ABidikianMD and @YaleIMed alumni @MaxStahlMD and Jan Bewersdorf and @SmilowCancer f…
0
3
0
@ABidikianMD
Aram Bidikian
2 months
0
0
4
@ABidikianMD
Aram Bidikian
2 months
RT @Dr_AmerZeidan: I look forward to presenting these data as menin inhibitors continue to firmly cement their place in the management of #…
0
3
0
@ABidikianMD
Aram Bidikian
2 months
RT @MarkDSiegel1: Celebrating the @TradIMYale fellowship match! We know how to party @YaleIMed
Tweet media one
0
17
0
@ABidikianMD
Aram Bidikian
2 months
RT @DrOnyemaOgbuagu: Published in NEJM. Our paper on lenacapavir showing 96% reduction in new HIV infections among men + gender diverse in…
0
24
0
@ABidikianMD
Aram Bidikian
3 months
0
0
1